Primary Site >> Stomach Cancer
Gene >> RAB3D
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Polymorphisms in DNA repair genes and associations with cancer risk. PMID: 12496039 |
Ref: Radiation therapy and combined modality treatment of gastrointestinal carcinomas. PMID: 16524667 |
Ref: Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer. PMID: 17948223 Ref: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. PMID: 17978289 |
Ref: S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. PMID: 18282805 Ref: Bioresorbable membrane to reduce postoperative small bowel obstruction in patients with gastric cancer: a randomized clinical trial. PMID: 18438113 Ref: D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. PMID: 18669424 |
Ref: The CHOLEGAS study: multicentric randomized, blinded, controlled trial of gastrectomy plus prophylactic cholecystectomy versus gastrectomy only, in adults submitted to gastric cancer surgery with curative intent. PMID: 19445661 Ref: Evaluation of double tract reconstruction after total gastrectomy in patients with gastric cancer: prospective randomized controlled trial. PMID: 19548028 |
Ref: Postoperative chemoradiotherapy in gastric cancer--a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy. PMID: 19690058 Ref: RAB26 and RAB3D are direct transcriptional targets of MIST1 that regulate exocrine granule maturation. PMID: 20038531 Ref: Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report--a phase III multicenter, prospective, randomized Trial (KLASS Trial). PMID: 20160637 Ref: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. PMID: 20728210 |
Ref: Worldwide clinical interventional studies on leading causes of death: a descriptive analysis. PMID: 21550817 Ref: Worldwide behavioral research on major global causes of mortality. PMID: 21558465 Ref: Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS). PMID: 21810227 |
Ref: Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. PMID: 22226517 Ref: A decade in gastric cancer curative surgery: Evidence of progress (1999-2009). PMID: 22530078 Ref: Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. PMID: 22658128 Ref: A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II). PMID: 22824079 Ref: Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma - a randomized, controlled pilot study. PMID: 23033982 |
Ref: Recurrent desmoids determine outcome in patients with Gardner syndrome: a cohort study of three generations of an APC mutation-positive family across 30 years. PMID: 23114473 Ref: Clinical application of image-enhanced minimally invasive robotic surgery for gastric cancer: a prospective observational study. PMID: 23207683 Ref: Prospective randomized controlled trial (phase III) to comparing laparoscopic distal gastrectomy with open distal gastrectomy for gastric adenocarcinoma (KLASS 01). PMID: 23396494 Ref: Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities. PMID: 23403682 Ref: Morbidity and mortality after laparoscopic gastrectomy for advanced gastric cancer: results of a phase II clinical trial. PMID: 23404155 Ref: Novel CDH1 germline mutations identified in Chinese gastric cancer patients. PMID: 23431106 Ref: Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial. PMID: 23742033 Ref: Long-term outcomes of laparoscopy-assisted distal gastrectomy for early gastric cancer: result of a randomized controlled trial (COACT 0301). PMID: 23793805 Ref: Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer. PMID: 23822578 Ref: Detection of circulating tumour cells in gastric and hepatocellular carcinoma: a systematic review. PMID: 23908550 Ref: Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma. PMID: 23930209 Ref: Helicobacter pylori-Induced Chronic Gastritis and Assessing Risks for Gastric Cancer. PMID: 23983680 Ref: A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors. PMID: 24252402 Ref: The effect of perioperative immunonutrition on the phagocytic activity of blood platelets in advanced gastric cancer patients. PMID: 24363760 Ref: Translation Elongation Rate Measurement of Epstein-Barr Virus Strain GD1. PMID: 25250137 |
Ref: Phase I clinical trial of vaccination with LY6K-derived peptide in patients with advanced gastric cancer. PMID: 23613128 Ref: Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. PMID: 24094768 Ref: Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma. PMID: 24100112 Ref: Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START). PMID: 24366758 Ref: GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. PMID: 24628950 Ref: FAIRY: a randomized controlled patient-blind phase III study to compare the efficacy and safety of intravenous ferric carboxymaltose (Ferinject(R)) to placebo in patients with acute isovolemic anemia after gastrectomy - study protocol for a randomized con PMID: 24708660 Ref: Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer. PMID: 24728035 Ref: Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. PMID: 25012265 Ref: Simvastatin plus capecitabine-cisplatin versus placebo plus capecitabine-cisplatin in patients with previously untreated advanced gastric cancer: a double-blind randomised phase 3 study. PMID: 25218337 Ref: Thymidylate synthase genotype-directed chemotherapy for patients with gastric and gastroesophageal junction cancers. PMID: 25232828 Ref: Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. PMID: 25240821 Ref: Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients. PMID: 25380654 Ref: Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. PMID: 25439693 Ref: Anti-angiogenic therapies for advanced esophago-gastric cancer. PMID: 25538401 |
Ref: A phase I study of farletuzumab, a humanized anti-folate receptor alpha monoclonal antibody, in patients with solid tumors. PMID: 25380636 Ref: Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study. PMID: 25416687 Ref: Postoperative chemoradiotherapy vs. preoperative chemoradiotherapy for locally advanced (operable) gastric cancer: clarifying the role and technique of radiotherapy. PMID: 25642342 Ref: Surgical techniques, open versus minimally invasive gastrectomy after chemotherapy (STOMACH trial): study protocol for a randomized controlled trial. PMID: 25873249 Ref: Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer. PMID: 25914908 Ref: Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers. PMID: 25915780 Ref: Efficacy of laparoscopic subtotal gastrectomy with D2 lymphadenectomy for locally advanced gastric cancer: the protocol of the KLASS-02 multicenter randomized controlled clinical trial. PMID: 25939684 Ref: Systematic review and meta-analysis of enhanced recovery programmes in gastric cancer surgery. PMID: 26004350 Ref: Phase II/III study of second-line chemotherapy comparing irinotecan-alone with S-1 plus irinotecan in advanced gastric cancer refractory to first-line treatment with S-1 (JACCRO GC-05). PMID: 26109630 Ref: Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS). PMID: 26216386 Ref: Glycemic Variation in Tumor Patients with Total Parenteral Nutrition. PMID: 26228214 Ref: S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot study. PMID: 26439700 Ref: Enhanced recovery after surgery with laparoscopic radical gastrectomy for stomach carcinomas. PMID: 26715818 |
Ref: Detection of precancerous gastric lesions and gastric cancer through exhaled breath. PMID: 25869737 Ref: Exploratory phase II trial in a multicenter setting to evaluate the clinical value of a chemosensitivity test in patients with gastric cancer (JACCRO-GC 04, Kubota memorial trial). PMID: 26385385 Ref: Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer. PMID: 26510663 Ref: Phase II trial of dacomitinib in patients with HER2-positive gastric cancer. PMID: 26581547 Ref: The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis. PMID: 26754295 Ref: Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. PMID: 26836587 Ref: Randomized clinical trial comparing long-term quality of life for Billroth I versus Roux-en-Y reconstruction after distal gastrectomy for gastric cancer. PMID: 26840944 Ref: Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial. PMID: 26857702 Ref: Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. PMID: 26874901 Ref: Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin). PMID: 26983912 Ref: Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer. PMID: 27003363 Ref: Laparoscopic versus open gastrectomy for gastric cancer. PMID: 27030300 Ref: Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study. PMID: 27138582 Ref: Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial. PMID: 27157491 Ref: Accuracy of Magnetically Controlled Capsule Endoscopy, Compared With Conventional Gastroscopy, in Detection of Gastric Diseases. PMID: 27211503 Ref: A Phase II prospective nonrandomized trial of magnetic resonance imaging-guided hematopoietic bone marrow-sparing radiotherapy for gastric cancer patients with concurrent chemotherapy. PMID: 27217780 Ref: Capecitabine plus paclitaxel induction treatment in gastric cancer patients with liver metastasis: a prospective, uncontrolled, open-label Phase II clinical study. PMID: 27256000 Ref: Novel STAT 3 inhibitors for treating gastric cancer. PMID: 27322026 Ref: A phase I trial of the trifunctional anti Her2 x anti CD3 antibody ertumaxomab in patients with advanced solid tumors. PMID: 27387446 Ref: Role of omentectomy as part of radical surgery for gastric cancer. PMID: 27550526 Ref: Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program. PMID: 27582078 Ref: The effect of neoadjuvant chemotherapy and chemoradiotherapy on exercise capacity and outcome following upper gastrointestinal cancer surgery: an observational cohort study. PMID: 27589870 Ref: To Excavate Biomarkers Predictive of the Response for Capecitabine plus RAD001 through Nanostring-Based Multigene Assay in Advanced Gastric Cancer Patients. PMID: 27994652 Ref: The Effects of Anti-inflammatory Drug Treatment in Gastric Cancer Prevention: an Update of a Meta-analysis. PMID: 27994661 |
Ref: Ultrasonically Activated Shears Reduce Blood Loss without Increasing Inflammatory Reactions in Open Distal Gastrectomy for Cancer: A Randomized Controlled Study. PMID: 27613551 Ref: Randomized, controlled trial comparing clinical outcomes of 3D and 2D laparoscopic surgery for gastric cancer: an interim report. PMID: 27826781 Ref: Laparoscopic Radical Gastrectomy for Resectable Advanced Gastric Cancer Within Enhanced Recovery Programs: A Prospective Randomized Controlled Trial. PMID: 27875094 Ref: Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway. PMID: 27913881 Ref: LJM716 in Japanese patients with head and neck squamous cell carcinoma or HER2-overexpressing breast or gastric cancer. PMID: 27942917 Ref: Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial. PMID: 28163000 Ref: [Experience and present situation of Western China Gastric Cancer Collaboration]. PMID: 28338153 Ref: Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study. PMID: 28343975 Ref: Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer. PMID: 28424889 Ref: Postoperative chemotherapy with S-1 plus oxaliplatin versus S-1 alone in locally advanced gastric cancer (RESCUE-GC study): a protocol for a phase III randomized controlled trial. PMID: 28536493 Ref: Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-la PMID: 28566227 Ref: Body mass index and risk of gastric cancer: A 30-year follow-up study in the Linxian general population trial cohort. PMID: 28594442 Ref: Effects of Community Screening for Helicobacter pylori: 13-Year Follow-Up Evaluation of a Randomized Controlled Trial. PMID: 28606845 Ref: Multicenter Phase 2 Study about the Safety of No Antimicrobial Prophylaxis Use in Low-Risk Patients Undergoing Laparoscopic Distal Gastrectomy for Gastric Carcinoma (KSWEET-01 Study). PMID: 28656047 Ref: Effect of a Proton Pump Inhibitor on Tumor Bleeding Prevention in Unresectable Gastric Cancer Patients: a Double-Blind, Randomized, Placebo-Controlled Trial. PMID: 28680717 Ref: Nut and peanut butter consumption and the risk of esophageal and gastric cancer subtypes. PMID: 28768652 Ref: ERas is constitutively expressed in full term placenta of pregnant cows. PMID: 28787666 Ref: Effectiveness of Helicobacter pylori eradication in the prevention of primary gastric cancer in healthy asymptomatic people: A systematic review and meta-analysis comparing risk ratio with risk difference. PMID: 28817628 Ref: A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer. PMID: 28899363 Ref: A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer. PMID: 28911091 Ref: A Novel Roux-en-Y Reconstruction Involving the Use of Two Circular Staplers after Distal Subtotal Gastrectomy for Gastric Cancer. PMID: 28970956 Ref: A Phase 1/1b tolerability study of rilotumumab alone or in combination with cisplatin and capecitabine in Japanese patients with gastric cancer. PMID: 28973403 Ref: Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial. PMID: 29103871 Ref: [Value of serum human epithelial growth factor receptor 2 extracellular domain and circulating tumor cells in evaluating therapeutic response in advanced gastric cancer]. PMID: 29178102 |
Ref: Comparison of 3D laparoscopic gastrectomy with a 2D procedure for gastric cancer: A phase 3 randomized controlled trial. PMID: 28845769 Ref: Predictive factors of trastuzumab-based chemotherapy in HER2 positive advanced gastric cancer: a single-center prospective observational study. PMID: 29168107 Ref: Phase II trial of preoperative chemoradiation plus perioperative SOX chemotherapy in patients with locally advanced gastric cancer. PMID: 29194623 Ref: Comparison of 3D laparoscopic gastrectomy with a 2D procedure for gastric cancer: A phase 3 randomized controlled trial. PMID: 29195739 Ref: Staging laparoscopy for locally advanced gastric cancer in Chinese patients: a multicenter prospective registry study. PMID: 29321007 Ref: Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11. PMID: 29372461 Ref: The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers. PMID: 29409462 Ref: Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy. PMID: 29438463 Ref: Ramucirumab for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum- or fluoropyrimidine-containing combination therapy in Japanese patients: a phase 2, open-label study. PMID: 29508095 Ref: Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial. PMID: 29543932 Ref: Long-term trastuzumab (Herceptin(R)) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer. PMID: 29544445 Ref: Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer. PMID: 29562147 Ref: A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer. PMID: 29587677 Ref: Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. PMID: 29650363 Ref: Chilean Gastric Cancer Task Force: A study protocol to obtain a clinical and molecular classification of a cohort of gastric cancer patients. PMID: 29668600 Ref: Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives. PMID: 29730461 Ref: Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer. PMID: 29743043 Ref: Compliance with an Enhanced Recovery After a Surgery Program for Patients Undergoing Gastrectomy for Gastric Carcinoma: A Phase 2 Study. PMID: 29789971 Ref: A prospective study on the changes and clinical significance of pre-operative and post-operative circulating tumor cells in resectable gastric cancer. PMID: 29925382 Ref: A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer. PMID: 29936063 Ref: Feasibility and Effects of a Postoperative Recovery Exercise Program Developed Specifically for Gastric Cancer Patients (PREP-GC) Undergoing Minimally Invasive Gastrectomy. PMID: 29984062 Ref: Multimodal Enhanced Recovery After Surgery (ERAS) Program is the Optimal Perioperative Care in Patients Undergoing Totally Laparoscopic Distal Gastrectomy for Gastric Cancer: A Prospective, Randomized, Clinical Trial. PMID: 30051365 Ref: A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer. PMID: 30089457 Ref: Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a ra PMID: 30092843 Ref: Concordance Study Between IBM Watson for Oncology and Clinical Practice for Patients with Cancer in China. PMID: 30181315 Ref: Extensive intraperitoneal lavage to eliminate intraperitoneal tumor cells in gastrectomy with D2 lymphadenectomy for gastric cancer. PMID: 30185117 Ref: CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resecta PMID: 30200910 Ref: Up-regulation and tumor-promoting role of SPHK1 were attenuated by miR-330-3p in gastric cancer. PMID: 30281914 Ref: Study on safety of laparoscopic total gastrectomy for clinical stage I gastric cancer: the protocol of the CLASS02-01 multicenter randomized controlled clinical trial. PMID: 30285673 Ref: The efficacy and safety of apatinib for refractory malignancies: a review and meta-analysis. PMID: 30323627 Ref: Reporting of outcomes in gastric cancer surgery trials: a systematic review. PMID: 30337308 Ref: Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial. PMID: 30355453 Ref: Systematic vs. on-demand early palliative care in gastric cancer patients: a randomized clinical trial assessing patient and healthcare service outcomes. PMID: 30357555 Ref: Randomized controlled trial comparing short-term outcomes of laparoscopic and open spleen-preserving splenic hilar lymphadenectomy for advanced proximal gastric cancer: An interim report. PMID: 30380145 Ref: Short-term surgical outcomes of laparoscopy-assisted versus open D2 distal gastrectomy for locally advanced gastric cancer in North China: a multicenter randomized controlled trial. PMID: 30386984 |